{
  "original_problem_text": "[예시 문제5]  T 세포 탈진 억제 약물 재활용(drug repositioning) 후보 예측\nT 세포 탈진(exhaustion)은 만성 감염, 종양 미세환경에서 반복 자극을 받은 T 세포가 기능을 상실하는 현상으로, 면역항암제의 반응성 저하와 치료 실패의 중요한 원인이다. 탈진을 역전시키는 약물 또는 조합을 발굴하는 것은 면역치료 혁신의 핵심 과제로 여겨진다.\n본 문제의 목표는 공개된 약물–유전자·전사체 데이터베이스를 통합하여, T 세포 탈진 유전자 시그니처를 역전(reversal)시킬 수 있는 약물 후보를 예측하고 그 근거를 제시하는 것이다.\n\n\n입력 데이터 Q5\n* exhaustion_signature → T 세포 탈진 관련 상향/하향 조절 유전자 목록\n아래는  Drug-related Open Data 를 참고할 것\n* 약물–표적 단백질/유전자 연결 정보\n* 이미 임상·전임상에서 사용되거나 연구 중인 약물 정보\n\n\n아래 요구사항을 충족하는 분석 전략을 제시하라.\n\n\n핵심 포인트:\n* 약물–표적 네트워크 이해\n* 탈진 시그니처를 기반으로 한 signature reversal 접근 실습\n* 약물 우선순위화 및 작용 기전 가설 도출\n\n\n(A) T 세포 탈진 시그니처 분석\n(B) 약물–유전자 네트워크 기반 후보 탐색\n(C) 약물 후보 선정 및 기전 가설 제시",
  "problem_id": "t_cell_exhaustion_drug_repositioning",
  "main_problem_definition": "Design an analysis strategy to predict drug repositioning candidates that can reverse T cell exhaustion by integrating exhaustion gene signatures with public drug–target and drug–transcriptomic datasets, and to prioritize drugs with plausible mechanisms of action.",
  "sub_problems": [
    {
      "id": "SINGLE",
      "title": "Integrated Strategy for Predicting T Cell Exhaustion-Reversing Drug Candidates",
      "description": "Propose a comprehensive analysis strategy that (A) analyzes the T cell exhaustion gene signature, (B) integrates drug–gene/target network information to identify drugs capable of reversing the signature, and (C) prioritizes candidate drugs while formulating mechanistic hypotheses for how they may alleviate T cell exhaustion. The strategy should explicitly address how signature reversal is quantified, how network information is leveraged, and how final candidates are ranked and interpreted.",
      "suggested_approach": "First, characterize the exhaustion signature by separating up- and down-regulated genes, performing pathway and transcription factor enrichment (e.g., GSEA, GSVA) to define core exhausted T cell programs. Second, apply a signature reversal framework by matching the exhaustion signature against drug-induced transcriptional profiles (e.g., connectivity score–based methods inspired by CMap/LINCS concepts) and integrating drug–target gene networks to assess whether drug targets antagonize exhaustion-associated pathways. Network propagation or random-walk approaches can be used to score proximity between drug targets and exhaustion genes. Third, prioritize drugs by combining reversal scores, network proximity, clinical status (approved vs. investigational), and target druggability. Finally, generate mechanistic hypotheses by mapping top-ranked drugs to known immunological pathways (e.g., PD-1 signaling, TCR signaling, metabolic reprogramming, epigenetic regulation) and proposing how modulation of these targets could restore T cell function.",
      "DB_flag": 1,
      "DB_list": "exhaustion_signature"
    }
  ]
}